Cryostat Microbiome Equipment Market - Growth, Trends, Covid-19 Impact, and Forecasts (2022 – 2027)

The Cryostat Microbiome Equipment Market is segmented by Product (Manual Cryostat Microtome Equipment, Semi-automatic Cryostat Microtome Equipment and Automatic Microtome Cryostat Equipment), End User (Hospitals, Ambulatory Surgical Centers and Diagnostic & Research Laboratories) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The report offers the value (in USD (US Dollar) million) for the above segments.

Market Snapshot

Cryostat Microbiome Equipment Market Overview
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 6.89 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Cryostat Microbiome Equipment Market is projected to register a CAGR of 6.89% during the forecast period (2022 to 2027).

The healthcare system has witnessed enormous challenges as a result of the COVID-19 pandemic. All outpatient treatments were postponed or restricted during the COVID-19 pandemic to ​reduce the risk of viral transmission as most chronic therapies were regarded as non-urgent. The cryostat microtome equipment is widely used in diagnostic and research laboratories for the study of histopathology of tissues. COVID-19 had severely impacted the research on chronic diseases such as cancer. An article titled “Impact of the COVID-19 Pandemic on Cancer Researchers: A Qualitative Study of Events to Inform Mitigation Strategies” published in the journal of Frontiers in Public Health in November 2021 discussed the impacts of the COVID-19 pandemic on cancer researchers. The article listed various factors such as financial resources, limited access to patients for research, decreased patient access to cancer care, staffing issues, administrative delays, or supply chain issues as the major limitations for the decline in the quantity of cancer research. Such a lack of trained personnel to handle cryostat microbiome equipment and disruptions in the supply chain is expected to have a significant impact on the growth of the market. 

However, with the rise of the pandemic, increasing research in the immunohistochemistry of the COVID-19 infected tissues has positively impacted the growth of the cryostat microtome equipment market. For instance, an article presented in the Elsevier journal of Immunology in September 2021 titled “Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy” studied the efficacy of neutralizing antibodies for COVID-19 treatment implemented the use of cryo-immunohistology of organs for further studies. Such an increase in the use of cryostat microtome equipment is expected to boost the growth of the market during the forecast period.

Major chronic diseases such as cancer, cardiovascular diseases, chronic lung disease, stroke, Alzheimer’s, diabetes, and chronic kidney disease are on the rise all over the world, which is adding to the growth of the cryostat microbiome equipment market.​ Cancer is a leading cause of death all around the world, accounting for around 10 million deaths in 2020. According to the GLOBOCAN 2020 report, the total number of people in the world affected by cancer in 2020 accounts for around 19,292,789 cases. The number is estimated to rise to 28,887,940 cases by 2040. ​According to the International Diabetes Federation Diabetes Atlas Tenth edition 2021, in 2021, around 537 million adults all over the world were found to have diabetes; with the numbers projected to grow to 643 million by 2030 and 783 million by 2045. The large population affected by chronic diseases and the increase in the necessity of cryostat microbiome equipment for the ease of diagnosis and treatment of such diseases is expected to propel the growth of the cryostat microbiome equipment market.​

Thus the above-mentioned factors are expected to drive the growth of the market during the forecast period.

Scope of the Report

As per the scope of this report, the cryostat microbiome equipment is a specialized precision cutting instrument that can accurately and repeatedly cut slices of sections from a block of embedded tissue at very low temperatures (around -20°C to -30°C). The cryostat microbiome equipment uses a cooling chamber for the cryofixation of the tissues to ensure speed and accurate slicing. The equipment is mostly used in diagnostic and research laboratories for the study of histopathology of tissues. The cryostat microbiome equipment market is segmented by Product (Manual Cryostat Microtome Equipment, Semi-automatic Cryostat Microtome Equipment and Automatic Microtome Cryostat Equipment), End User (Hospitals, Ambulatory Surgical Centers and Diagnostic & Research Laboratories) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The Market report also covers the estimated market sizes and trends across major regions globally. The report offers values in (in USD million) for the above segments.

By Product
Manual Cryostat Microtome Equipment
Semi-automatic Cryostat Microtome Equipment
Automatic Microtome Cryostat Equipment
End User
Hospitals
Ambulatory Surgical Centers
Diagnostic & Research Laboratories
Geography
North America
Europe
Asia-Pacific
Middle-East and Africa
South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Diagnostic & Research Laboratories Segment is Expected to Hold a Major Market Share in the Cryostat Microbiome Equipment Market.

The diagnostic & research laboratories holds the major segment in the cryostat microbiome equipment market. The cryostat microbiome equipment holds an important part in the study of immunohistochemistry and histopathological studies of tissues, for example, biopsies. An article published in the journal of Proceedings of the National Academy of Sciences in December 2020 titled “Deep learning extended depth-of-field microscope for fast and slide-free histology” showed that cryostat microbiome are widely used methods for cutting thin sections of tissues in a short processing time period.

Another article titled “Histological-Based Stainings using Free-Floating Tissue Sections” published in the Journal of Visualized Experiments in August 2021 discussed the application of freefloating method to fluorescent immunohistochemistry staining. The article indicated that the cryostat microbiome equipment are the most preferrred method for slicing and collecting tissues for many researchers. The study aimed to reduce the processing time taken for staining the sliced frozen tissues. Such increase in research studies enabling the ease of use of the cryostat microbiome equipment are expected to propel the growth of the cryostat microbiome equipment market during the forecast period.

The increasing number of cancer cases and the associated treatments requiring the use of cryostat microbiome equipment for the disgnosis of the infected tissues are likely to drive the growth of the market. For example, an article titled “Diagnostic Biopsy via In-Office Frozen Sections for Clinical Nonmelanoma Skin Cancer” presented in the journal of Dermatologic Surgery in February 2021 focused on measuring the accuracy and outcomes of biopsy via frozen sections for clinical non melanoma skin cancer. The study indicated that the in-office biopsy via frozen sections were highly accurate in confirmation of the non melanoma skin cancer cells and that the practice might help in speeding up the diagnosis and treatment of the disease thereby enhancing outcomes and patient satisfaction. The increasing research on the study of diagnosis and treatment of cancer cases with the use of cryostat microbiome equipment is expected to boost the growth of the studied market over the forecast period.

Projected Number of Cancer Cases (in millions), Global, 2020 - 2040

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period (2022 – 2027).

The rise in the adoption of highly advanced techniques and systems in the manufacturing of cryostat microbiome equipments and the technological advancements made in immunohistochemistry studies is expected to boost the growth of the market in the North American region. The high awareness among the population on the availability of innovative cryostat microbiome equipment models in the market contributes to the high market growth in the region.

The rising number of chronic disease cases in the North American region is adding to the growth of the cryostat microbiome equipment market.​ Cancer is one of the top ten leading causes of death in the United States. According to the GLOBOCAN 2020 report, the total number of people in the United States affected by cancer in 2020 accounts to around 2,281,658 cases. The number is estimated to rise to 3,123,452 cases by 2040. ​According to the International Diabetes Federation, in 2021, total number of diabetes in adults in united States were 32,215,300 with a prevalence of over 13%. ​TheCenter for Disease Control and Prevention in 2021 reported that 37million United States Adults are estimated to have chronic kidney disease in 2021. The report by the Center for Disease prevention and Control in 2020 showed that around 15.7 million Americans are affected by chronic lower respiratory Disease.​ The large population affected by the chronic diseases and the increase in the necessity of cryostat microbiome equipment for the ease of diagnosis and treatment of such diseases is expected to propel the growth of the cryostat microbiome equipment market.​

Also, the increasing healthcare expenditure in the United States is expected to drive the demand for the cryostat microbiome equipment market in this region. According to the United States Centers for Medicare & Medicaid Services’ National Health Expenditure Data 2020, the healthcare expenditure grew upto 9.7% to USD 4.1 trillion in 2020 and accounted for around 19.7% of the Gross Domestic Product. The expenditure is projected to reach USD 6.2 trillion by 2028. The rise in the healthcare expenditure in the United States region is likely to boost the growth of the cryostat microbiome equipment market over the forecast period of the study.

Thus the increasing necessity for cryostat microbiome equipment coupled with increasing investment in the health care department is known to propel the growth of the market in this region.

Cryostat Microbiome Equipment Market - Growth by Region

Competitive Landscape

The Cryostat Microbiome Equipment Market is fragmented competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Amos Scientific Pty. Ltd., Bright Instruments Ltd., Cardinal Health, Epredia, Hacker Instruments & Industries Inc., Histo-Line Laboratories S.R.L., Kalstein France, Labtron Equipment Ltd., Leica Microsystems Nussloch GmbH, Medimeas Instruments, Sakura Finetek Usa Inc., Slee Medical Gmbh, Spensers World, Tanner Scientific Inc., Zhejiang Jinhua Kedi Instrumental Equipment Co., Ltd. and others.

Recent Development

  • In September 2021, sureCore developed a (Complementary Metal-Oxide Semiconductor) CMOS IP library suitable for operations at extremely low temperatures required for quantum computing applications, enabling the design of cryo-CMOS control chips co-located with qubits in a cryostat.
  • in June 2022 the director of the Regional Institute of Medical Sciences (RIMS), Manipur, inaugurated Cryostat, which helped in achieving a milestone for cancer treatment. 

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and market definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Chronic Diseases

      2. 4.2.2 Rising Healthcare Expenditure

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Skilled Professionals

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Manual Cryostat Microtome Equipment

      2. 5.1.2 Semi-automatic Cryostat Microtome Equipment

      3. 5.1.3 Automatic Microtome Cryostat Equipment

    2. 5.2 End User

      1. 5.2.1 Hospitals

      2. 5.2.2 Ambulatory Surgical Centers

      3. 5.2.3 Diagnostic & Research Laboratories

    3. 5.3 Geography

      1. 5.3.1 North America

      2. 5.3.2 Europe

      3. 5.3.3 Asia-Pacific

      4. 5.3.4 Middle-East and Africa

      5. 5.3.5 South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Amos Scientific Pty. Ltd.

      2. 6.1.2 Bright Instruments Ltd.

      3. 6.1.3 Cardinal Health

      4. 6.1.4 Epredia

      5. 6.1.5 Hacker Instruments & Industries Inc.

      6. 6.1.6 Histo-Line Laboratories S.R.L.

      7. 6.1.7 Kalstein France

      8. 6.1.8 Labtron Equipment Ltd.

      9. 6.1.9 Leica Microsystems Nussloch GmbH

      10. 6.1.10 Medimeas Instruments

      11. 6.1.11 Sakura Finetek Usa Inc.

      12. 6.1.12 Slee Medical Gmbh

      13. 6.1.13 Spensers World

      14. 6.1.14 Tanner Scientific Inc.

      15. 6.1.15 Zhejiang Jinhua Kedi Instrumental Equipment Co., Ltd.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Cryostat Microbiome Equipment Market market is studied from 2019 - 2027.

The Global Cryostat Microbiome Equipment Market is growing at a CAGR of 6.89% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Epredia , Histo-Line Laboratories S.R.L. , Leica Microsystems Nussloch GmbH , Sakura Finetek USA , Slee Medical GmbH are the major companies operating in Global Cryostat Microbiome Equipment Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!